3 Key Takeaways
Plain English Summary- 01Core Finding
Here we identify a shared autoreactive signature of pregnancy in pregnant sera (n = 2,719) relative to never-pregnant controls (n = 130), using proteome-wide autoantibody profiling.
- 02Study Evidence
Tested in a animal models (n = 2,719) at the preclinical stage.
- 03Practical Meaning
Early laboratory or animal model findings — human trials are still needed to confirm safety and benefit.
What This Means for You
IL1RA localizes to placental endothelial (blood-vessel lining) adherens junctions, suggesting a role in vascular integrity. These findings identify a term pregnancy humoral immune program and shared changes preceding preterm delivery, including anti-IL1RA, which may have direct pathogenic consequences.
The Discovery
Preterm birth is associated with breakdown of maternal-fetal tolerance and remains the leading cause of global mortality in young children. However, the role of self-reactive antibodies has been limited to a handful of pathogenic allo- and autoantibodies linked to pregnancy complications. Here we identify a shared autoreactive signature of pregnancy in pregnant sera (n = 2,719) relative to never-pregnant controls (n = 130), using proteome-wide autoantibody profiling. Across eight human pregnancy cohorts, we define autoreactivities associated with preterm birth by comparing preterm (n = 688) and term (n = 1,505) pregnancies. Within the signature, antibodies to IL1 receptor antagonist (IL1RA) induce resorption, inflammation and vascular malperfusion in pregnant mice.
How It Works, Simply
This immunology research focuses on inflammation · Antibodies · Immune response. Researchers evaluated it using an animal models (n = 2,719) at the preclinical stage of medical research.
3 Key Takeaways
Clinical Takeaways- 01Core Finding
Here we identify a shared autoreactive signature of pregnancy in pregnant sera (n = 2,719) relative to never-pregnant controls (n = 130), using proteome-wide autoantibody profiling.
- 02Study Evidence
Tested in a animal models (n = 2,719) at the preclinical stage.
- 03Practical Meaning
Early laboratory or animal model findings — human trials are still needed to confirm safety and benefit.
Biological Mechanism & Study Design
Study Design & Cohort
Animal models
Animal models (n = 2,719) · Preclinical
Biological Pathway & Modality
Inflammation · Antibodies · Immune response
Intervention: Evidence for maternal autoantibodies in the pathogenesis of preterm birth
Experimental Findings & Endpoints
Preterm birth is associated with breakdown of maternal-fetal tolerance and remains the leading cause of global mortality in young children.
However, the role of self-reactive antibodies has been limited to a handful of pathogenic allo- and autoantibodies linked to pregnancy complications. Here we identify a shared autoreactive signature of pregnancy in pregnant sera (n = 2,719) relative to never-pregnant controls (n = 130), using proteome-wide autoantibody profiling.
Across eight human pregnancy cohorts, we define autoreactivities associated with preterm birth by comparing preterm (n = 688) and term (n = 1,505) pregnancies. Within the signature, antibodies to IL1 receptor antagonist (IL1RA) induce resorption, inflammation and vascular malperfusion in pregnant mice.
Clinical Translation & Practice Context
IL1RA localizes to placental endothelial adherens junctions, suggesting a role in vascular integrity.
These findings identify a term pregnancy humoral immune program and shared changes preceding preterm delivery, including anti-IL1RA, which may have direct pathogenic consequences.
The Bottom Line · Clinical Pearl
“These findings identify a term pregnancy humoral immune program and shared changes preceding preterm delivery, including anti-IL1RA, which may have direct pathogenic consequences.”
Published in Nature Immunology · Current Stage: Preclinical
